Trial-based cost-effectiveness analysis of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) versus DSAEK

被引:5
|
作者
Simons, Rob W. P. [1 ]
Dickman, Mor M. [1 ]
van den Biggelaar, Frank J. H. M. [1 ]
Dirksen, Carmen D. [2 ]
Van Rooij, Jeroen [3 ]
Remeijer, Lies [3 ]
Van der Lelij, Allegonda [4 ,5 ]
Wijdh, Robert H. J. [6 ]
Kruit, Pieter J. [7 ]
Nuijts, Rudy M. M. A. [1 ]
机构
[1] Maastricht Univ, Med Ctr, Univ Eye Clin Maastricht, POB 5800, NL-6202 AZ Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands
[3] Rotterdam Eye Hosp, Rotterdam, Netherlands
[4] Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands
[5] Cent Mil Hosp, Dept Ophthalmol, Utrecht, Netherlands
[6] Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands
[7] Euro Tissue Bank, Beverwijk, Netherlands
关键词
corneal transplantation; cost-effectiveness; costs; Descemet stripping automated endothelial keratoplasty; Fuchs' endothelial dystrophy; quality-adjusted life years; ultrathin Descemet stripping automated endothelial keratoplasty; POSTERIOR LAMELLAR KERATOPLASTY; PENETRATING KERATOPLASTY; OUTCOMES;
D O I
10.1111/aos.14126
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To evaluate the cost-effectiveness of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) versus standard DSAEK. Methods A cost-effectiveness analysis using data from a multicentre randomized clinical trial was performed. The time horizon was 12 months postoperatively. Sixty-four eyes of 64 patients with Fuchs' endothelial dystrophy were included and randomized to UT-DSAEK (n = 33) or DSAEK (n = 31). Relevant resources from healthcare and societal perspectives were included in the cost analysis. Quality-adjusted life years (QALYs) were determined using the Health Utilities Index Mark 3 questionnaire. The main outcome was the incremental cost-effectiveness ratio (ICER; incremental societal costs per QALY). Results Societal costs were euro9431 (US$11 586) for UT-DSAEK and euro9110 (US$11 192) for DSAEK. Quality-adjusted life years (QALYs) were 0.74 in both groups. The ICER indicated inferiority of UT-DSAEK. The cost-effectiveness probability ranged from 37% to 42%, assuming the maximum acceptable ICER ranged from euro2500-euro80 000 (US$3071-US$98 280) per QALY. Additional analyses were performed omitting one UT-DSAEK patient who required a regraft [ICER euro9057 (US$11 127) per QALY, cost-effectiveness probability: 44-62%] and correcting QALYs for an imbalance in baseline utilities [ICER euro23 827 (US$29 271) per QALY, cost-effectiveness probability: 36-59%]. Furthermore, the ICER was euro2101 (US$2581) per patient with clinical improvement in best spectacle-corrected visual acuity (>= 0.2 logMAR) and euro3274 (US$4022) per patient with clinical improvement in National Eye Institute Visual Functioning Questionnaire-25 composite score (>= 10 points). Conclusion The base case analysis favoured DSAEK, since costs of UT-DSAEK were higher while QALYs were comparable. However, additional analyses revealed no preference for UT-DSAEK or DSAEK. Further cost-effectiveness studies are required to reduce uncertainty.
引用
收藏
页码:756 / 763
页数:8
相关论文
共 50 条
  • [41] Histopathological findings of failed grafts following Descemet's stripping automated endothelial keratoplasty (DSAEK)
    Alkatan, Hind
    Al-Rajhi, Ali
    Al-Shehri, Ali
    Khairi, Ali
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2012, 26 (01) : 79 - 85
  • [42] Visual Outcomes in Phakic Patients Undergoing Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK)
    Tsui, J. Y.
    Wagoner, M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [43] Immunological graft rejection with Khodadoust line after "Descemet stripping automated endothelial keratoplasty" (DSAEK)
    Fiorentzis, M.
    Viestenz, A.
    Seitz, B.
    OPHTHALMOLOGE, 2015, 112 (09): : 783 - 787
  • [44] Outcomes of simultaneous Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) and intraocular lens exchange surgery
    Awidi, Abdelhalim
    Daoud, Yassine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [45] Influence of donor lamella thickness on visual acuity after Descemet's stripping automated endothelial keratoplasty (DSAEK) [Einfluss der Spenderlamellendicke auf die Sehschärfe nach "Descemet's stripping automated endothelial keratoplasty" (DSAEK)]
    Maier A.-K.B.
    Gundlach E.
    Klamann M.K.J.
    Gonnermann J.
    Bertelmann E.
    Joussen A.M.
    Torun N.
    Rieck P.W.
    Der Ophthalmologe, 2014, 111 (2): : 128 - 134
  • [46] Cost-Effectiveness Analysis of Descemet's Membrane Endothelial Keratoplasty Versus Descemet's Stripping Endothelial Keratoplasty in the United States
    Gibbons, Allister
    Leung, Ella H.
    Yoo, Sonia H.
    OPHTHALMOLOGY, 2019, 126 (02) : 207 - 213
  • [47] Early Results of Descemet-Stripping and Automated Endothelial Keratoplasty (DSAEK) in Patients With Glaucoma Drainage Devices
    Riaz, Kamran M.
    Sugar, Joel
    Tu, Elmer Y.
    Edward, Deepak P.
    Wilensky, Jacob T.
    Namavari, Abed
    Djalilian, Ali R.
    CORNEA, 2009, 28 (09) : 959 - 962
  • [48] The Use of Polarization Filters to Detect the Edge of the Descemet's Stripping Automated Endothelial Keratoplasty(DSAEK) Graft
    Ide, Takeshi
    Yoo, Sonia H.
    O'Brien, Terrence P.
    OPEN OPHTHALMOLOGY JOURNAL, 2009, 3 : 3 - 5
  • [49] Outcomes of complex Descemet's stripping automated endothelial keratoplasty (DSAEK) in eyes with significant ocular comorbidities
    Ma, Kevin K.
    Wang, Yvonne
    Sanjiv, Nayan
    Jurkunas, Ula V.
    Yin, Jia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [50] Corneal allograft rejection after Descemet stripping automated endothelial keratoplasty (DSAEK): report of three cases
    Ponchel, C.
    Arne, J. -L.
    Malecaze, F.
    Fournie, P.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2009, 32 (04): : 257 - 262